Eurofins Scientific SE (ESF.VI)

Eurofins Scientific SE (ESF.VI) — VMCI valuation read

Composite valuation read on ESF.VI: VMCI 51/100 against a Healthcare sector median of 50. The 1-point above-median print is the headline number for Eurofins Scientific SE, and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for ESF.VI: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on ESF.VI: ESF.VI trades at 21.0x earnings, 17% above the Healthcare median of 18.0x; ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%); net debt to EBITDA of 0.1x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

ESF.VI rose 0.1% over the trailing 7 days, with a -4.2% read on a 30-day basis.